Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells

Lauren Friedman, Li Lin, Sarah Ball, Tanios Bekaii-Saab, James Fuchs, Pui Kai Li, Chenglong Li, Jiayuh Lin

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Curcumin, a yellow pigment and the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development in several types of cancer. However, its low bioavailability and potency prevent it from being effective in most chemotherapeutic applications. One potential means of circumventing this problem has been the creation of synthetic curcumin analogues. We tested the efficacy of two such analogues, known as FLLL11 and FLLL12, in human pancreatic cancer cell lines. We compared the impact of curcumin with FLLL11 and FLLL12 on cell viability in five different pancreatic cancer cell lines. Although all three compounds were capable of lowering viability in all cell lines tested, FLLL11 and FLLL12 (IC50 values between 0.28-3.2 and 0.91 -3.43 μmol/l, respectively) were substantially more potent than curcumin (IC50 values between 8.67 and 20.35 μmol/l). In addition, FLLL11 and FLLL12 inhibited phosphorylation of signal transducer and activator of transcription 3 and AKT, two cell signaling pathways frequently found persistently active in many forms of cancer. Furthermore, FLLL11 and FLLL12 were found to be more effective than curcumin in inducing apoptosis as evidenced by increased cleavage of PARP and caspase-3 in pancreatic cancer cell lines. These results indicate that the curcumin analogues, FLLL11 and FLLL12, are more effective than curcumin in inhibiting cell viability and inducing apoptosis, and may have translational potential as chemopreventive or therapeutic agents for pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)444-449
Number of pages6
JournalAnti-Cancer Drugs
Volume20
Issue number6
DOIs
StatePublished - Jul 1 2009
Externally publishedYes

Fingerprint

Curcumin
Pancreatic Neoplasms
Human Activities
Growth
Cell Line
Inhibitory Concentration 50
Cell Survival
Apoptosis
Curcuma
STAT3 Transcription Factor
Neoplasms
Caspase 3
Biological Availability
Carcinogenesis
Phosphorylation

Keywords

  • AKT
  • Curcumin
  • Pancreatic cancer
  • Signal transducer and activator of transcription 3

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research

Cite this

Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells. / Friedman, Lauren; Lin, Li; Ball, Sarah; Bekaii-Saab, Tanios; Fuchs, James; Li, Pui Kai; Li, Chenglong; Lin, Jiayuh.

In: Anti-Cancer Drugs, Vol. 20, No. 6, 01.07.2009, p. 444-449.

Research output: Contribution to journalArticle

Friedman, Lauren ; Lin, Li ; Ball, Sarah ; Bekaii-Saab, Tanios ; Fuchs, James ; Li, Pui Kai ; Li, Chenglong ; Lin, Jiayuh. / Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells. In: Anti-Cancer Drugs. 2009 ; Vol. 20, No. 6. pp. 444-449.
@article{1c8f1626d2f64114a59a4799e62b84f2,
title = "Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells",
abstract = "Curcumin, a yellow pigment and the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development in several types of cancer. However, its low bioavailability and potency prevent it from being effective in most chemotherapeutic applications. One potential means of circumventing this problem has been the creation of synthetic curcumin analogues. We tested the efficacy of two such analogues, known as FLLL11 and FLLL12, in human pancreatic cancer cell lines. We compared the impact of curcumin with FLLL11 and FLLL12 on cell viability in five different pancreatic cancer cell lines. Although all three compounds were capable of lowering viability in all cell lines tested, FLLL11 and FLLL12 (IC50 values between 0.28-3.2 and 0.91 -3.43 μmol/l, respectively) were substantially more potent than curcumin (IC50 values between 8.67 and 20.35 μmol/l). In addition, FLLL11 and FLLL12 inhibited phosphorylation of signal transducer and activator of transcription 3 and AKT, two cell signaling pathways frequently found persistently active in many forms of cancer. Furthermore, FLLL11 and FLLL12 were found to be more effective than curcumin in inducing apoptosis as evidenced by increased cleavage of PARP and caspase-3 in pancreatic cancer cell lines. These results indicate that the curcumin analogues, FLLL11 and FLLL12, are more effective than curcumin in inhibiting cell viability and inducing apoptosis, and may have translational potential as chemopreventive or therapeutic agents for pancreatic cancer.",
keywords = "AKT, Curcumin, Pancreatic cancer, Signal transducer and activator of transcription 3",
author = "Lauren Friedman and Li Lin and Sarah Ball and Tanios Bekaii-Saab and James Fuchs and Li, {Pui Kai} and Chenglong Li and Jiayuh Lin",
year = "2009",
month = "7",
day = "1",
doi = "10.1097/CAD.0b013e32832afc04",
language = "English (US)",
volume = "20",
pages = "444--449",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells

AU - Friedman, Lauren

AU - Lin, Li

AU - Ball, Sarah

AU - Bekaii-Saab, Tanios

AU - Fuchs, James

AU - Li, Pui Kai

AU - Li, Chenglong

AU - Lin, Jiayuh

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Curcumin, a yellow pigment and the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development in several types of cancer. However, its low bioavailability and potency prevent it from being effective in most chemotherapeutic applications. One potential means of circumventing this problem has been the creation of synthetic curcumin analogues. We tested the efficacy of two such analogues, known as FLLL11 and FLLL12, in human pancreatic cancer cell lines. We compared the impact of curcumin with FLLL11 and FLLL12 on cell viability in five different pancreatic cancer cell lines. Although all three compounds were capable of lowering viability in all cell lines tested, FLLL11 and FLLL12 (IC50 values between 0.28-3.2 and 0.91 -3.43 μmol/l, respectively) were substantially more potent than curcumin (IC50 values between 8.67 and 20.35 μmol/l). In addition, FLLL11 and FLLL12 inhibited phosphorylation of signal transducer and activator of transcription 3 and AKT, two cell signaling pathways frequently found persistently active in many forms of cancer. Furthermore, FLLL11 and FLLL12 were found to be more effective than curcumin in inducing apoptosis as evidenced by increased cleavage of PARP and caspase-3 in pancreatic cancer cell lines. These results indicate that the curcumin analogues, FLLL11 and FLLL12, are more effective than curcumin in inhibiting cell viability and inducing apoptosis, and may have translational potential as chemopreventive or therapeutic agents for pancreatic cancer.

AB - Curcumin, a yellow pigment and the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development in several types of cancer. However, its low bioavailability and potency prevent it from being effective in most chemotherapeutic applications. One potential means of circumventing this problem has been the creation of synthetic curcumin analogues. We tested the efficacy of two such analogues, known as FLLL11 and FLLL12, in human pancreatic cancer cell lines. We compared the impact of curcumin with FLLL11 and FLLL12 on cell viability in five different pancreatic cancer cell lines. Although all three compounds were capable of lowering viability in all cell lines tested, FLLL11 and FLLL12 (IC50 values between 0.28-3.2 and 0.91 -3.43 μmol/l, respectively) were substantially more potent than curcumin (IC50 values between 8.67 and 20.35 μmol/l). In addition, FLLL11 and FLLL12 inhibited phosphorylation of signal transducer and activator of transcription 3 and AKT, two cell signaling pathways frequently found persistently active in many forms of cancer. Furthermore, FLLL11 and FLLL12 were found to be more effective than curcumin in inducing apoptosis as evidenced by increased cleavage of PARP and caspase-3 in pancreatic cancer cell lines. These results indicate that the curcumin analogues, FLLL11 and FLLL12, are more effective than curcumin in inhibiting cell viability and inducing apoptosis, and may have translational potential as chemopreventive or therapeutic agents for pancreatic cancer.

KW - AKT

KW - Curcumin

KW - Pancreatic cancer

KW - Signal transducer and activator of transcription 3

UR - http://www.scopus.com/inward/record.url?scp=67249125471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67249125471&partnerID=8YFLogxK

U2 - 10.1097/CAD.0b013e32832afc04

DO - 10.1097/CAD.0b013e32832afc04

M3 - Article

C2 - 19384191

AN - SCOPUS:67249125471

VL - 20

SP - 444

EP - 449

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 6

ER -